Application of Accepted Use Criteria for the Treatment of Developmental Dysplasia of the Hip Decreases the Number of Infants Treated With a Pavlik Harness

被引:0
|
作者
Murphy-Zane, Margaret S. [1 ,2 ,3 ]
Carry, Patrick M. [1 ,2 ]
Salton, Reba L. [2 ]
Hadley Miller, Nancy [1 ,2 ]
Holmes, Kaley [2 ]
Freeman, Tyler [1 ]
Belton, Matthew [1 ]
Kohuth, Brian [2 ]
Burke, Deborah [2 ]
Georgopoulos, Gaia [1 ,2 ]
机构
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Childrens Hosp Colorado, Orthoped Inst, Aurora, CO USA
[3] Childrens Hosp Colorado, Dept Pediat Orthoped Surg, 13123 East 16th Ave, Aurora, CO 80045 USA
关键词
DDH; developmental dysplasia of the hip; accepted use criteria; AUC; Pavlik; Graf; CONGENITAL DISLOCATION; EARLY DIAGNOSIS; ULTRASOUND; ABNORMALITIES; INSTABILITY; MANAGEMENT; ACCURACY; UPDATE; POWER;
D O I
10.1097/BPO.0000000000002295
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background:This analysis examined how the application of the American Academy of Orthopedic Surgeons appropriate use criteria (AUC) for developmental dysplasia of the hip in infants would change treatment patterns and outcomes for Graf IIA hips at a single quaternary pediatric hospital. Methods:After Institutional Review Board approval, patient medical records were reviewed and data were collected. Graf IIa hips were defined as alpha angle (AA) 50 to 59 degrees. AA and femoral head coverage (FHC) were measured from initial and 6-month ultrasounds and acetabular index (AI) was measured from radiographs at 6 months of age. Instability (positive Ortolani and Barlow tests) was noted. On the basis of the American Academy of Orthopedic Surgeons AUC for managing developmental dysplasia of the hip, hips were further categorized as normal (FHC >= 45%), borderline (FHC 35% to 44%), or dysplastic (FHC <35%). Results:Overall, 13% (49/371) of Graf IIa hips (AA 50 to 59 degrees) were dysplastic (FHC <35%). Total 24% (89/371) were clinically unstable. Total 42% (37/89) of unstable Graf IIa hips were dysplastic. Only 4% of stable Graf IIa hips were dysplastic (12/282). Out of 371 Graf IIa hips, 256 were treated with Pavlik harness (n=250) or Rhino brace (n=6). Among stable, nondysplastic (SND) hips (those with normal and borderline FHC >= 35%), 33% (52/158) were treated because of a more severe contralateral side. If the AUC had been applied, 67% (106/158) of SND Graf IIa hips would not have been treated. Among the n=162 hips that returned for a 6-month radiograph, there was no difference in AI in the 115 treated and 47 untreated SND hips (mean difference treatment vs. no treatment: -1.5, 95% CI, -3.1 to 0.2, P=0.0808). Conclusions:Using AUC recommendations, our center could reduce the number of SND Graf IIa hips we treat by 67%. Although 24% of Graf IIa hips were clinically unstable and 13% were dysplastic based on FHC, most Graf IIa hips had normal or borderline FHC per the AUC and may do well with observation and follow-up ultrasound at 12 weeks old.
引用
收藏
页码:E138 / E143
页数:6
相关论文
共 50 条
  • [41] A Comparison of Pavlik Harness Treatment Regimens for Dislocated But Reducible (Ortolani plus ) Hips in Infantile Developmental Dysplasia of the Hip
    Hines, Adam C.
    Neal, David C.
    Beckwith, Terri
    Jo, ChanHee
    Kim, Harry K. W.
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2019, 39 (10) : 505 - 509
  • [42] Sonographic monitoring of the treatment of developmental disturbances of the hip by the Pavlik harness
    Malkawi, H
    JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B, 1998, 7 (02): : 144 - 149
  • [43] Impact of Failed Pavlik Harness Treatment on the Outcomes Following Closed or Open Reduction in Developmental Dysplasia of the Hip
    Yong Liu
    Lisheng Kan
    Jun Sun
    Yapeng Zhang
    Indian Journal of Orthopaedics, 2022, 56 : 1634 - 1639
  • [44] Education of parents in Pavlik harness application for developmental dysplasia of the hip using a validated simulated learning module
    Gargan, Kate E.
    Bradley, Catharine S.
    Maxwell, Alexandra
    Moktar, Joel
    Wedge, John H.
    Murnaghan, M. Lucas
    Kelley, Simon P.
    JOURNAL OF CHILDRENS ORTHOPAEDICS, 2016, 10 (04) : 289 - 293
  • [45] MECHANICS OF HIP DYSPLASIA REDUCTION IN INFANTS WITH THE PAVLIK HARNESS USING PATIENT-SPECIFIC GEOMETRY
    Huayamave, Victor
    Rose, Christopher
    Zwawi, Mohammed
    Divo, Eduardo
    Moslehy, Faissal
    Kassab, Alain
    Price, Charles
    PROCEEDINGS OF THE ASME INTERNATIONAL MECHANICAL ENGINEERING CONGRESS AND EXPOSITION, 2014, VOL 3, 2015,
  • [46] Incidence of Nerve Palsies During Pavlik Harness Treatment for Developmental Dysplasia of the Hip A Retrospective Cohort Study
    Gross, Preston W.
    Chipman, Danielle E.
    Nagra, Kiranpreet
    Tracey, Olivia C.
    Jones, Ruth H.
    Blanco, John S.
    Sink, Ernest L.
    Scher, David M.
    Dodwell, Emily R.
    Doyle, Shevaun M.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2024, 106 (06) : 525 - 530
  • [47] Effect of the Pavlik harness used in the treatment of developmental dysplasia of the hip on unaided sitting and independent walking age
    Ucpunar, Hanifi
    Sevencan, Ahmet
    Erbas, Anil
    Ozyalvac, Osman Nuri
    Akpinar, Evren
    Bayhan, Avni Ilhan
    JOURNAL OF CHILDRENS ORTHOPAEDICS, 2024, 18 (01) : 79 - 84
  • [48] Closed reduction and plaster immobilization: an alternative solution for patients with developmental dysplasia of the hip who failed Pavlik harness treatment
    Zhou, Ping
    Zhang, Jianqiang
    Dan, Tangzi
    Xu, Taotao
    Kang, Xiaopeng
    Hang, Yong
    Zhou, You
    ANZ JOURNAL OF SURGERY, 2023, 93 (03) : 663 - 668
  • [49] Known risk factors of the developmental dysplasia of the hip predicting more severe clinical presentation and failure of Pavlik harness treatment
    Vilma Lankinen
    Mika Helminen
    Karim Bakti
    Jarmo Välipakka
    Hannele Laivuori
    Anna Hyvärinen
    BMC Pediatrics, 23
  • [50] Follow-up after successful treatment for developmental dysplasia of the hip using a Pavlik harness IS TWO YEARS ENOUGH?
    Larwood, J. P. J.
    Idowu, O.
    Elliott, K. G. B.
    Lindisfarne, E. A.
    Aarvold, A.
    BONE & JOINT JOURNAL, 2025, 107B (04) : 495 - 500